The booming business of shaming young men
Online health providers like Hims & Hers Health and Ro target young men's insecurities, offering products for issues like hair loss and erectile dysfunction. Critics warn about potential risks and ethical concerns.
Read original articleOnline health providers are profiting by exploiting the fears of young men, offering products for issues like hair loss and erectile dysfunction through direct-to-consumer telehealth companies. These companies, such as Hims & Hers Health and Ro, have seen significant financial success, with a market cap of billions of dollars. They target young men's insecurities, promising convenience and privacy in obtaining medications. While these services offer accessibility and convenience, they may lack comprehensive evaluations and appropriate medical oversight, potentially leading to unnecessary treatments and higher costs for patients. Critics raise concerns about the quality of care provided by these platforms, highlighting the risks of receiving prescriptions without thorough medical assessments. Despite the convenience they offer, direct-to-consumer health services may prioritize selling drugs over providing optimal medical care, raising ethical considerations about their practices. While these platforms aim to address medical needs that individuals might otherwise ignore, the financial incentives involved may influence the care provided, emphasizing the importance of informed decision-making when using such services.
Related
The Opaque Industry Inflating Prices for Prescription Drugs
Pharmacy Benefit Managers (PBMs) like CVS Health, Cigna, and UnitedHealth Group are criticized for increasing prescription drug costs in the US. Despite claims of cost reduction, PBMs allegedly steer towards expensive drugs, charge high markups, and prioritize financial gains over patients. Lawmakers are scrutinizing their practices for potential price inflation and anticompetitive behavior.
Hims & Hers Selling GLP-1 Injection That’s Not FDA Approved, From Shady Supplier
Hims & Hers sells non-FDA approved weight loss drug through loophole, raising concerns about patient safety, legality, and supplier's history of fraud. Executives sold shares amid risks of legal consequences.
Adderall Shortage Caused by DEA Quotas on Controlled Substances
The Adderall shortage, linked to DEA quotas, impacts ADHD patients. Despite efforts to address the issue, the DEA's inflexible approach exacerbates the crisis, prompting calls for systemic reform to alleviate suffering.
Middlemen have outsized influence on drug prices due to market consolidation,FTC
The FTC highlights PBMs' dominance in U.S. drug pricing. Top PBMs control 79% of claims, raising concerns about cost inflation, lack of transparency, and conflicts of interest. Regulation and scrutiny are needed.
The Surgeon General Says Social Media Is Like Tobacco. He's Wrong
The U.S. Surgeon General proposes warning labels on social media akin to tobacco products for potential harm on adolescents. Experts caution against oversimplification, advocating for a nuanced approach considering both positive and negative impacts.
‘disinterested parties’ is a bold statement to make when there are plenty of cases of pharma reps giving out gifts and causing conflicts of interest with doctors. Corruption can occur anywhere, at least with DTC the motives are clear.
DTC found the opportunity to make it convenient for people to not have to go to the doctor, so of course they're going to go for the more convenient option.
However, the way this article is written, it makes me wonder if it was paid for by CVS, Walgreens, Rite-Aid, etc. They are the ones who lose out in this market, aren't they?
I don’t think ozempic or any injectable should be prescribed via platforms like this. I think they have a lot of time needed to mature, so far they are not far off pill mills.
The article mentioned the fellow got generic viagra, which I’ve heard happens on these platforms too, they promise name brand viagra and show pictures of the same then send you a ton of generic viagra. Obviously a profit play there.
Related
The Opaque Industry Inflating Prices for Prescription Drugs
Pharmacy Benefit Managers (PBMs) like CVS Health, Cigna, and UnitedHealth Group are criticized for increasing prescription drug costs in the US. Despite claims of cost reduction, PBMs allegedly steer towards expensive drugs, charge high markups, and prioritize financial gains over patients. Lawmakers are scrutinizing their practices for potential price inflation and anticompetitive behavior.
Hims & Hers Selling GLP-1 Injection That’s Not FDA Approved, From Shady Supplier
Hims & Hers sells non-FDA approved weight loss drug through loophole, raising concerns about patient safety, legality, and supplier's history of fraud. Executives sold shares amid risks of legal consequences.
Adderall Shortage Caused by DEA Quotas on Controlled Substances
The Adderall shortage, linked to DEA quotas, impacts ADHD patients. Despite efforts to address the issue, the DEA's inflexible approach exacerbates the crisis, prompting calls for systemic reform to alleviate suffering.
Middlemen have outsized influence on drug prices due to market consolidation,FTC
The FTC highlights PBMs' dominance in U.S. drug pricing. Top PBMs control 79% of claims, raising concerns about cost inflation, lack of transparency, and conflicts of interest. Regulation and scrutiny are needed.
The Surgeon General Says Social Media Is Like Tobacco. He's Wrong
The U.S. Surgeon General proposes warning labels on social media akin to tobacco products for potential harm on adolescents. Experts caution against oversimplification, advocating for a nuanced approach considering both positive and negative impacts.